ISSN:1357-8170    

DOI:10.1002/pdi.1960110102

出版商:John Wiley&Sons, Ltd.    

年代:1994

数据来源: WILEY

ISSN:1357-8170    

DOI:10.1002/pdi.1960110103

出版商:John Wiley&Sons, Ltd.    

年代:1994

数据来源: WILEY

ISSN:1357-8170    

DOI:10.1002/pdi.1960110104

出版商:John Wiley&Sons, Ltd.    

年代:1994

数据来源: WILEY

ISSN:1357-8170    

DOI:10.1002/pdi.1960110105

出版商:John Wiley&Sons, Ltd.    

年代:1994

数据来源: WILEY

ISSN:1357-8170    

DOI:10.1002/pdi.1960110106

出版商:John Wiley&Sons, Ltd.    

年代:1994

数据来源: WILEY

ISSN:1357-8170    

DOI:10.1002/pdi.1960110107

出版商:John Wiley&Sons, Ltd.    

年代:1994

数据来源: WILEY

ISSN:1357-8170    

DOI:10.1002/pdi.1960110108

出版商:John Wiley&Sons, Ltd.    

年代:1994

数据来源: WILEY

摘要:

AbstractThis study consists of two parts: first, a survey of the current selfmonitoring preferences, attitudes and practices of 148 non‐insulindependent diabetic (NIDDM) patients on oral hypoglycaemic agents from three general practices in North Cornwall, and second, a clinical trial involving 24 of these patients who were randomly allocated to either home blood glucose monitoring or urine testing.The survey revealed wide variations in the method, timing, and frequency of home‐monitoring tests, and many unhelpful or unnecessary tests were performed. Most patients (71%) preferred urine testing, but significantly more patients in one practice used blood testing (p =<0.001). The trial showed no significant difference in the diabetes control of the blood testers and urine testers over a six month period.Blood testing is rapldly taking over from urine testing as the principal home‐monitoring method for all diabetics, but this study suggests that, for most NIDDM patients, this uncomfortable, unpopular and expensive method offers no advantage over urine te

ISSN:1357-8170    

DOI:10.1002/pdi.1960110109

出版商:John Wiley&Sons, Ltd.    

年代:1994

数据来源: WILEY

摘要:

AbstractThe effectiveness of home glucose monltoring (HGM) was assessed In patients over the age of 40 years with dlabetes. Results were obtalned from 158 patients who were seen consecutlvely in the clinic. Of Insulin‐treated patients, 78.0% performed self‐monitorlng of blood glucose (SMBG), whlist 76.3% of non‐insulin‐treated patients performed urlne testing alone at home. Only 5.6% of patients failed to undertake any HGM and these were all non‐insulin‐treated patients. Insulin‐treated patients performing SMBG did not have an improved HbA1compared with those doing urine tests alone (SMBG 10.3±1.8%, Urine 9.9±1.8%). only 26.6% of patients performing SMBG felt confident to change their own insulin regimens. Patients performing urine tests seemed generally more satisfied with their HGM (91. 5%) than those performing urine blood tests (63.0% p<6;0.01). In summary, virtually all patients performed some form of HGM, the majority being those on insulin who were attempting SMBG. With SMBG there was no improvement in glycaemic control, few patients changed their own insulin and many patlents would have preferred urine testing alone. Patients should be carefulty selected

ISSN:1357-8170    

DOI:10.1002/pdi.1960110110

出版商:John Wiley&Sons, Ltd.    

年代:1994

数据来源: WILEY

摘要:

AbstractOne thousand and sixteen insulin‐treated patients from 84 UK diabetes centres were entered into a 12‐week open study to assess the acceptability and safety of the B‐DTM(Becton Dickinson) Pen with HumulinTM(human insulin [prb], Eli Lilly&Co) cartridges. Patients completed an acceptability questionnair after six and 12 weeks' use of the Pen. Patients were asked to score various Pen characteristics on a five‐point scale of very easy to very difficult which included: changing the needle and storing and carrying the Pen; setting the insulin dose; fitting a new cartridge; injecting insulin; reading the dosage markings and noting when the cartridge was empty. Nine hundred and ten patients (90%) completed the study.The commonest insulin used was Humulin M3, a fixed mixture of 30% soluble and 70% isophane insulin (33% of patients), and the most popular dosing regimen was twice daily, (65% of patients). The average daily dose of insulin was 39 units.Three per cent of patients reported some Pen malfunction during the study, and 9% of patients at week 6 and 16% at week 12 reported Pen breakage. All aspects of Pen usage were assessed as 'very easy/fairly easy' by over 84% of patients at both week 6 and week 12; the Pen compared favourably to previous injection methods. Ninety percent of patients who previously used a needle and syringe and 62% who previously used another pen device opted to continue using the B‐D Pen at the end of

ISSN:1357-8170    

DOI:10.1002/pdi.1960110111

出版商:John Wiley&Sons, Ltd.    

年代:1994

数据来源: WILEY